News Detail
  • Source : Business Wire
  • Date : 2017-05-15
  • Companies : BIOQUAL, Inc.

BIOQUAL Presents Financial Results for Third Quarter of Fiscal Year 2017


ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) (www.bioqual.com):


































































































































































































































































































































































               
      Nine Months Ended       Three Months Ended
      February 28,     February 29,       February 28,     February 29,
     

2017


   

2016


     

2017


   

2016


                                   
Revenue     $ 27,716,798     $ 23,398,669       $ 9,068,275     $ 8,796,046
                                   
Income Before Income Tax     $ 4,949,235     $ 2,538,783      

$


1,459,486    

$


947,882
                                   
Net Income     $ 2,858,135     $ 1,466,083      

$


842,786    

$


547,482
                                   

Basic Earnings per Share of Common Stock


   

$



3.20


   

$



1.64


     

$



.94


   

$



.61


                                   

Diluted Earnings per Share of Common Stock


   

$



3.20


   

$



1.64


     

$



.94


   

$



.61


                                   

Weighted Average Number of Shares Outstanding For Basic Earnings


     

893,416


     

893,466


       

893,416


     

893,466


                                   

Weighted Average Number of Shares Outstanding For Diluted Earnings


     

893,416


     

893,466


       

893,416


     

893,466


                           


For more detail related to the fiscal year 2017 third quarter results, please visit our web site at www.bioqual.com.


Statements herein that are not descriptions of historical facts are forward-looking and subject to risk and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts and obtain new contracts; the Company’s ability to obtain new commercial contracts; the performance of the business acquired in the ABL acquisition; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual cost incurred in performing its contracts and the Company’s ability to manage its costs; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.




Contacts


BIOQUAL, Inc.
Mark G. Lewis, Ph.D., CEO
240-404-7654


Warning

Close